Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cholangiocarcinoma × Doxorubicin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 34 Lymphoma, Large B-Cell, Diffuse 21 Lymphoma 17 Sarcoma 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Carcinoma, Hepatocellular 10 Lymphoma, Non-Hodgkin 8 Leukemia 8 Hodgkin Disease 8 Multiple Myeloma 6 Neuroblastoma 5 Lymphoma, Follicular 5 Immunoblastic Lymphadenopathy 5 Ovarian Neoplasms 4 Lymphoma, T-Cell, Peripheral 4 Liver Neoplasms 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Leiomyosarcoma 3 Burkitt Lymphoma 3 Wilms Tumor 2 Rhabdomyosarcoma 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasms 2

Interventions

Gemcitabine 11 Oxaliplatin 7 Capecitabine 6 apatinib 5 tislelizumab 4 Radiofrequency Ablation 4 Fluorouracil 4 Cisplatin 4 sintilimab 3 lenvatinib 3 Surgical Procedures, Operative 3 Neoadjuvant Therapy 3 Leucovorin 3 Irinotecan 3 toripalimab 2 camrelizumab 2 Stents 2 Radiotherapy 2 Photochemotherapy 2 Immunotherapy 2 Hepatectomy 2 Everolimus 2 Cholangiopancreatography, Endoscopic Retrograde 2 Blood Specimen Collection 2 surufatinib 1 regorafenib 1 pemigatinib 1 niraparib 1 durvalumab 1 apixaban 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01920503 2019-02-27

CHOLANGIO

International Group of Endovascular Oncology

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡